ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,017Hybrid

European Journal of Immunology

Acronym:eurjimmu
•
Abbreviation (ISO):EUR. J. IMMUNOL
•
Identifier (ISSN):0014-2980(Print)/1521-4141(Online)
•
Publisher:Wiley-VCH Verlag
Clarivate IF (2026)
4.1↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for European Journal of Immunology

WoS Q2
24794.2520184.720194.420205.5320216.6920225.420234.520243.720254.12026
Annual Impact Factor Metric
Current (2026):4.1
Scopus SJR & RankScopus Q1
1.666
#2,017

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
235

235 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate4.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
189articles/year
65.19% Gold OA•78.87% Original Research

Aims & Scope

EJI is an immunology research journal, focusing on various aspects of immunology including, but not limited to: Basic: Adaptive immunity, Innate immunity, Leukocyte and lymphoid organ ontogeny, Molecular immunology and signaling, New technology, Tissue immunology and leukocyte trafficking Basic/Clinical studies*: Allergy and inflammation, Immunity to infection, Immunodeficiencies and autoimmunity, Transplantation and tolerance, Immunomodulation and Immune Therapies, Tumor immunology *Clinical studies EJI's editorial team understands the experimental restrictions of clinical/human studies. EJI considers descriptive clinical papers without a mechanism, provided that the studies are hypothesis-driven with a clear rationale and informative results that forward our understanding of immunological processes and disease.

Topics Covered (Recognized by AI)
BiologyMedicine88.6%Immunology85.9%Genetics85.6%Chemistry77.9%Biochemistry77.6%Immune system63.9%Internal medicine60.9%Antigen50.9%Cell biology45%Molecular biology42.8%In vitro42.5%Gene40.7%Antibody38%T cell35.5%Cytotoxic T cell29.2%Receptor27.5%CD823.5%Pathology22.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q2
Rank70/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank97/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.1
Articles / Year171
Total Citations64
2025
IF3.7
Articles / Year261
Total Citations729
2024
IF4.5
Articles / Year258
Total Citations1,561
2023
IF5.4
Articles / Year301
Total Citations2,913
2022
IF6.688
Articles / Year258
Total Citations2,832

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,017Scopus Q1SCImago Profile
Scopus Coverage:1971-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
1.666

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.31

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,691 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,519
3-Year Documents608
Citable Documents564

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

European Journal of Immunology (acronym: eurjimmu, abbr: EUR. J. IMMUNOL, ISSN: 0014-2980) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-VCH Verlag in United States since 1971. The periodical holds a Journal Impact Factor (JIF) of 4.10, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.666 (Q1), an H-index of 235.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 189 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,691 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-VCH Verlag
Publication Language
English
Frequency
Monthly
Founding Year
1971
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-V C H VERLAG GMBH, PO BOX 10 11 61, WEINHEIM, GERMANY, D-69451

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d2b03d7c-8018-40e8-904c-9595cf9c4a25
Database Updated: 2026-09-28